Danaher’s purchase of GE Healthcare biopharma unit wins conditional antitrust clearance in China (English version)
US medical equipment maker Danaher’s acquisition of the biopharma business of GE Healthcare Life Sciences was approved by China’s State Administration for Market Regulation on condition that the acquirer divest itself...To view the full article, register now.
Already a subscriber? Click here to view full article